Instrumenting the health care enterprise for discovery research in the genomic era.

Abstract excerpt

Tens of thousands of subjects may be required to obtain reliable evidence relating disease characteristics to the weak effects typically reported from common genetic variants. The costs of assembling, phenotyping, and studying these large populations are substantial, recently estimated at three billion dollars for 500,000 individuals. They are also decade-long efforts. We hypothesized that automation and analytic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Academic Medical Centers
• Share to Arthritis, Rheumatoid